v3.26.1
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 1,833 $ 1,541 $ 3,028 $ 3,730
General and administrative 1,251 1,164 2,582 2,369
Total operating expenses 3,084 2,705 5,610 6,099
Loss from operations (3,084) (2,705) (5,610) (6,099)
Other income (expense):        
Interest income 77 17 171 33
Other (expense) income, net 0 151 (2) 182
Net loss $ (3,007) $ (2,537) $ (5,441) $ (5,884)
Loss per share, basic (in dollars per share) $ (1.11) $ (3.36) $ (2.08) $ (8.64)
Loss per share, diluted (in dollars per share) $ (1.11) $ (3.36) $ (2.08) $ (8.64)
Weighted average number of shares of common stock, basic (in shares) 2,706,607 754,725 2,620,740 681,235
Weighted average number of shares of common stock, diluted (in shares) 2,706,607 754,725 2,620,740 681,235

Source